Daxor Corporation (DXR)

Jan 30, 2025

Where are the Opportunities in (DXR) - Stock Traders Daily

Jan 30, 2025

Jan 22, 2025

Reviewing Becton, Dickinson and Company (NYSE:BDX) and Daxor (NASDAQ:DXR) - Defense World

Jan 22, 2025

Jan 20, 2025

(DXR) Technical Pivots with Risk Controls - Stock Traders Daily

Jan 20, 2025

Jan 11, 2025

Head to Head Contrast: Daxor (NASDAQ:DXR) versus Titan Medical (NASDAQ:TMDIF) - Defense World

Jan 11, 2025

Jan 09, 2025

(DXR) Long Term Investment Analysis - Stock Traders Daily

Jan 09, 2025

Jan 09, 2025

Nemaura Medical (NASDAQ:NMRD) versus Daxor (NASDAQ:DXR) Head to Head Comparison - Defense World

Jan 09, 2025

Jan 02, 2025

Daxor (NYSEAMERICAN:DXR) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell? - Defense World

Jan 02, 2025

Jan 02, 2025

Daxor (NASDAQ:DXR) Shares Up 0.8% – Should You Buy? - Defense World

Jan 02, 2025

Dec 30, 2024

When (DXR) Moves Investors should Listen - Stock Traders Daily

Dec 30, 2024

Dec 26, 2024

Reviewing Embecta (NASDAQ:EMBC) and Daxor (NASDAQ:DXR) - Defense World

Dec 26, 2024

Dec 25, 2024

Daxor (NYSEAMERICAN:DXR) Stock Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World

Dec 25, 2024

Dec 18, 2024

Daxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum - GlobeNewswire

Dec 18, 2024

Dec 18, 2024

Daxor Expands Blood Analysis Service to Major Health Networks, Reports Record-Breaking Quarter - StockTitan

Dec 18, 2024

Dec 17, 2024

Daxor Expands Its BVA-100?? Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum - Marketscreener.com

Dec 17, 2024

Dec 11, 2024

Daxor corp CEO Michael Feldschuh acquires 45,000 shares By Investing.com - Investing.com Nigeria

Dec 11, 2024

Dec 10, 2024

Daxor corp CFO Michel acquires 4,750 shares at no cost By Investing.com - Investing.com Nigeria

Dec 10, 2024

Dec 10, 2024

Daxor's chief scientific officer acquires 32,000 shares By Investing.com - Investing.com Canada

Dec 10, 2024

Dec 10, 2024

Daxor's chief scientific officer acquires 32,000 shares - Investing.com

Dec 10, 2024

Dec 10, 2024

Daxor corp CFO Michel acquires 4,750 shares at no cost - Investing.com

Dec 10, 2024

Dec 10, 2024

Daxor corp CEO Michael Feldschuh acquires 45,000 shares - Investing.com

Dec 10, 2024

Dec 08, 2024

How the (DXR) price action is used to our Advantage - Stock Traders Daily

Dec 08, 2024

Dec 07, 2024

Daxor (NYSEAMERICAN:DXR) Stock Price Down 2.1% – Time to Sell? - Defense World

Dec 07, 2024

Nov 18, 2024

Daxor (NASDAQ:DXR) & Co-Diagnostics (NASDAQ:CODX) Critical Survey - Defense World

Nov 18, 2024

Oct 27, 2024

(DXR) On The My Stocks Page - Stock Traders Daily

Oct 27, 2024

Oct 09, 2024

DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24 - The Manila Times

Oct 09, 2024

Oct 09, 2024

DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC - GlobeNewswire

Oct 09, 2024

Oct 08, 2024

Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - The Manila Times

Oct 08, 2024

Oct 05, 2024

Long Term Trading Analysis for (DXR) - Stock Traders Daily

Oct 05, 2024

Sep 29, 2024

Short Interest in Daxor Co. (NASDAQ:DXR) Rises By 39.6% - Defense World

Sep 29, 2024

Sep 28, 2024

Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device - The Manila Times

Sep 28, 2024

Sep 19, 2024

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024 - GlobeNewswire

Sep 19, 2024

Sep 19, 2024

Daxor (NYSEAMERICAN:DXR) Stock Passes Above Two Hundred Day Moving Average of $0.00 - Defense World

Sep 19, 2024

Sep 14, 2024

(DXR) Technical Data - Stock Traders Daily

Sep 14, 2024

Sep 12, 2024

Daxor announces review published in journal on BVA - TipRanks

Sep 12, 2024

Sep 12, 2024

Newly Published Review Highlights the Pivotal Role of - GlobeNewswire

Sep 12, 2024

Sep 12, 2024

Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management - StockTitan

Sep 12, 2024

Sep 10, 2024

Daxor (NASDAQ:DXR) Price Target Raised to $24.75 at Ascendiant Capital Markets - Defense World

Sep 10, 2024

Sep 05, 2024

Daxor secures $300K from LaunchTN for blood analyzer tech - Investing.com India

Sep 05, 2024

Sep 05, 2024

Daxor receives $300K matching fund award from Launch Tennessee - TipRanks

Sep 05, 2024

Sep 05, 2024

Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee - GlobeNewswire

Sep 05, 2024

Sep 04, 2024

DXRDaxor Corporation Latest Stock News & Market Updates - StockTitan

Sep 04, 2024

Sep 04, 2024

Central Florida hospital implements Daxor BVA-100 blood volume diagnostic - TipRanks

Sep 04, 2024

Sep 04, 2024

Leading Central Florida Hospital Implements Daxor’s - GlobeNewswire

Sep 04, 2024

Sep 04, 2024

Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care - StockTitan

Sep 04, 2024

Sep 04, 2024

Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter - GlobeNewswire

Sep 04, 2024

Sep 03, 2024

Daxor reports doubled revenue, secures government contracts - Investing.com

Sep 03, 2024